Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Pontevedra (35)

2024

  1. Patient-reported outcome measures in severe asthma: an expert consensus

    Journal of Asthma, Vol. 61, Núm. 6, pp. 619-631

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  2. Las sustancias químicas relacionadas con el aumento de incidencia en el cáncer de tiroides: una revisión bibliográfica

    Nuevos horizontes para la investigación en salud desde un enfoque integrador (Asociación Universitaria de Educación y Psicología (ASUNIVEP)), pp. 321-328

  3. Off-label Prescription in Paediatric Dermatology: A Retrospective Observational Study in a Tertiary Hospital

    Acta Dermato-Venereologica, Vol. 103

  4. Relación e influencia de elementos minerales en el cáncer de tiroides: una revisión de la literatura

    Nuevos horizontes para la investigación en salud desde un enfoque integrador (Asociación Universitaria de Educación y Psicología (ASUNIVEP)), pp. 355-362

2022

  1. Development of a carbocysteine 10% + urea 5% cream for the topical treatment of congenital ichthyosis

    Farmacia Hospitalaria, Vol. 46, Núm. 2, pp. 51-56

  2. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  3. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

  4. The economic burden of pulmonary arterial hypertension in Spain

    BMC Pulmonary Medicine, Vol. 22, Núm. 1

  5. [Translated article] Effect of Drug Compounding on Quality of Life in Patients With Genodermatoses: A Cross-Sectional Study

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 6, pp. T543-T549

2021

  1. Baricitinib and tofacitinib in patients with rheumatoid arthritis: results of regular clinical practice

    Farmacia Hospitalaria, Vol. 45, Núm. 4, pp. 165-169

  2. Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice

    Clinical Therapeutics, Vol. 43, Núm. 4, pp. e111-e121

  3. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

  4. Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis

    Farmacia Hospitalaria, Vol. 45, Núm. 2, pp. 73-76

2020

  1. GLP1 Receptor Agonist and SGLT2 Inhibitor Combination: An Effective Approach in Real-world Clinical Practice

    Clinical Therapeutics, Vol. 42, Núm. 2, pp. e1-e12

  2. Re-initiation of treatment with sargramostim in a patient with pulmonary alveolar proteinosis

    European Journal of Clinical Pharmacy, Vol. 22, Núm. 3, pp. 175-177

2019

  1. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain

    Frontiers in Microbiology, Vol. 10, Núm. APR

2018

  1. Anakinra for the treatment of undifferentiated systemic auto-inflammatory disease

    European Journal of Clinical Pharmacy, Vol. 20, Núm. 6, pp. 337-339

  2. Topical and systemic therapeutic alternatives for the treatment of ichthyosis

    Piel, Vol. 33, Núm. 8, pp. 526-534

  3. Topical carbocysteine: A new option for the treatment of ichthyosis

    Pediatric Dermatology, Vol. 35, Núm. 6, pp. e357-e359